Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.62 USD
−440.24 M USD
1.83 B USD
127.95 M
About Alnylam Pharmaceuticals, Inc.
Sector
CEO
Yvonne L. Greenstreet
Headquarters
Cambridge
Website
Founded
2002
FIGI
BBG000BFGNJ5
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
ALNY5653584
Alnylam Pharmaceuticals, Inc. 1.0% 15-SEP-2027Yield to maturity
−2.02%
Maturity date
Sep 15, 2027
Explore more bonds
Curated watchlists where ALNY is featured.
Frequently Asked Questions
The current price of ALNY is 244.89 USD — it has decreased by −0.77% in the past 24 hours. Watch Alnylam Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Alnylam Pharmaceuticals, Inc. stocks are traded under the ticker ALNY.
ALNY stock has fallen by −3.25% compared to the previous week, the month change is a −17.40% fall, over the last year Alnylam Pharmaceuticals, Inc. has showed a 48.24% increase.
We've gathered analysts' opinions on Alnylam Pharmaceuticals, Inc. future price: according to them, ALNY price has a max estimate of 400.00 USD and a min estimate of 178.00 USD. Watch ALNY chart and read a more detailed Alnylam Pharmaceuticals, Inc. stock forecast: see what analysts think of Alnylam Pharmaceuticals, Inc. and suggest that you do with its stocks.
ALNY reached its all-time high on Oct 17, 2024 with the price of 304.39 USD, and its all-time low was 3.65 USD and was reached on Aug 18, 2004. View more price dynamics on ALNY chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALNY stock is 2.28% volatile and has beta coefficient of 0.93. Track Alnylam Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Alnylam Pharmaceuticals, Inc. there?
Today Alnylam Pharmaceuticals, Inc. has the market capitalization of 31.59 B, it has increased by 4.77% over the last week.
Yes, you can track Alnylam Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Alnylam Pharmaceuticals, Inc. is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
ALNY earnings for the last quarter are −0.87 USD per share, whereas the estimation was −0.92 USD resulting in a 5.09% surprise. The estimated earnings for the next quarter are −0.59 USD per share. See more details about Alnylam Pharmaceuticals, Inc. earnings.
Alnylam Pharmaceuticals, Inc. revenue for the last quarter amounts to 500.92 M USD, despite the estimated figure of 532.91 M USD. In the next quarter, revenue is expected to reach 579.59 M USD.
ALNY net income for the last quarter is −111.57 M USD, while the quarter before that showed −16.89 M USD of net income which accounts for −560.61% change. Track more Alnylam Pharmaceuticals, Inc. financial stats to get the full picture.
No, ALNY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 2.10 K employees. See our rating of the largest employees — is Alnylam Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Alnylam Pharmaceuticals, Inc. EBITDA is −132.15 M USD, and current EBITDA margin is −12.48%. See more stats in Alnylam Pharmaceuticals, Inc. financial statements.
Like other stocks, ALNY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Alnylam Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Alnylam Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Alnylam Pharmaceuticals, Inc. stock shows the buy signal. See more of Alnylam Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.